Sanginita Chemicals Past Earnings Performance
Past criteria checks 1/6
Sanginita Chemicals's earnings have been declining at an average annual rate of -46.8%, while the Chemicals industry saw earnings growing at 14.6% annually. Revenues have been declining at an average rate of 0.4% per year. Sanginita Chemicals's return on equity is 0.7%, and it has net margins of 0.2%.
Key information
-46.8%
Earnings growth rate
-47.7%
EPS growth rate
Chemicals Industry Growth | 17.7% |
Revenue growth rate | -0.4% |
Return on equity | 0.7% |
Net Margin | 0.2% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Sanginita Chemicals Limited (NSE:SANGINITA) Shares Fly 26% But Investors Aren't Buying For Growth
May 01Revenues Working Against Sanginita Chemicals Limited's (NSE:SANGINITA) Share Price Following 26% Dive
Mar 11Sanginita Chemicals Limited (NSE:SANGINITA) Surges 38% Yet Its Low P/S Is No Reason For Excitement
Jan 02These 4 Measures Indicate That Sanginita Chemicals (NSE:SANGINITA) Is Using Debt Reasonably Well
Dec 30Sanginita Chemicals (NSE:SANGINITA) Seems To Use Debt Quite Sensibly
Sep 05Is Sanginita Chemicals (NSE:SANGINITA) Using Too Much Debt?
Dec 13We Think Sanginita Chemicals (NSE:SANGINITA) Is Taking Some Risk With Its Debt
Feb 15Sanginita Chemicals (NSE:SANGINITA) Has A Somewhat Strained Balance Sheet
Jul 22Is Sanginita Chemicals (NSE:SANGINITA) Using Too Much Debt?
Mar 16Sanginita Chemicals Limited's (NSE:SANGINITA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 18Does Sanginita Chemicals (NSE:SANGINITA) Have A Healthy Balance Sheet?
Nov 26Revenue & Expenses Breakdown
How Sanginita Chemicals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 2,005 | 4 | 13 | 0 |
30 Jun 24 | 1,726 | 7 | 12 | 0 |
31 Mar 24 | 1,515 | 8 | 13 | 0 |
31 Dec 23 | 1,325 | 13 | 12 | 0 |
30 Sep 23 | 1,367 | 11 | 11 | 0 |
30 Jun 23 | 1,334 | 6 | 10 | 0 |
31 Mar 23 | 1,486 | 4 | 11 | 0 |
31 Dec 22 | 1,535 | 0 | 10 | 0 |
30 Sep 22 | 1,720 | -9 | 8 | 0 |
30 Jun 22 | 1,918 | -3 | 7 | 0 |
31 Mar 22 | 1,981 | 3 | 7 | 0 |
31 Dec 21 | 2,127 | 7 | 6 | 0 |
30 Sep 21 | 1,977 | 12 | 6 | 0 |
30 Jun 21 | 1,953 | 17 | 5 | 0 |
31 Mar 21 | 1,648 | 8 | 5 | 0 |
31 Dec 20 | 1,486 | 6 | 5 | 0 |
30 Sep 20 | 1,567 | 20 | 5 | 0 |
30 Jun 20 | 1,462 | 24 | 6 | 0 |
31 Mar 20 | 1,598 | 34 | 6 | 0 |
31 Dec 19 | 1,648 | 50 | 5 | 0 |
30 Sep 19 | 1,589 | 44 | 5 | 0 |
30 Jun 19 | 1,748 | 38 | 5 | 0 |
31 Mar 19 | 1,876 | 39 | 5 | 0 |
31 Mar 18 | 1,945 | 35 | 6 | 0 |
31 Mar 17 | 1,473 | 11 | 3 | 0 |
31 Mar 16 | 1,441 | 11 | 4 | 0 |
31 Mar 15 | 1,286 | 10 | 5 | 0 |
31 Mar 14 | 1,190 | 8 | 8 | 0 |
Quality Earnings: SANGINITA has high quality earnings.
Growing Profit Margin: SANGINITA's current net profit margins (0.2%) are lower than last year (0.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SANGINITA's earnings have declined by 46.8% per year over the past 5 years.
Accelerating Growth: SANGINITA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SANGINITA had negative earnings growth (-63.2%) over the past year, making it difficult to compare to the Chemicals industry average (8%).
Return on Equity
High ROE: SANGINITA's Return on Equity (0.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 12:54 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sanginita Chemicals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|